| Name | Title | Contact Details |
|---|
Steadman Hawkins Sports Medicine Foundation is a Vail, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Access Solutions is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Foster City, CA. To find more information about Health Access Solutions, please visit www.healthaccesssolutions.com
Caloptima Health Partnership is a Orange, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mohawk Valley Health System is an integrated healthcare delivery system which includes St. Elizabeth Medical Center and Faxton St. Luke`s Healthcare, serving Oneida, Herkimer and Madison counties. We offer inpatient, primary, multi-specialty and long-term care. Services also include bariatric surgery, maternal child services, stroke care, surgical services, orthopedic services, cancer care, dialysis, diabetes program, rehabilitation, home care, cardiac care, imaging, wound care, emergency services, urgent care, outpatient laboratory services and more.
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.